Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Blog | March 24, 2015

District Court Not Required to Reopen Appeal Period Following Erroneous ECF Notices

Blog | March 23, 2015

No Express Disclaimer Necessary to Limit Means-Plus-Function Claims to Embodiments Disclosed in the Specification

Blog | March 23, 2015

Narrow Independent Claims are Not Expanded by the Presence of Broad Dependents

Blog | March 16, 2015

Now is the Time to Protect Your Marks in Cuba

Blog | March 13, 2015

ITC Says it Has the Power to Stop Infringing Transmissions of Digital Materials

Blog | March 12, 2015

Ambiguous Phrase in Claims Not Indefinite Where Intrinsic Evidence Resolves the Ambiguity

Blog | March 11, 2015

Another interesting marking case

Blog | March 10, 2015

Interesting fact dispute regarding marking

Blog | March 09, 2015

Federal Circuit Precedential Decision: Use in Commerce Requires Sales and Rendering of Services, Advertising Alone is Insufficient

Blog | March 09, 2015

FDA Approves First Biosimilar Drug for US

Blog | March 09, 2015

FDA Approves First Biosimilar Drug for U.S.

Blog | March 04, 2015

No Lost Profits on Patented Products the Patentee Did Not Make or on Unpatented Products that Could Be Used Independently